Last reviewed · How we verify
NCT03279107
Effects of Different Types of Carbohydrates in Snacks and Beverages on Glycemia, Insulinemia and Appetite.
NA trial testing Soluble corn fiber in Pre Diabetes in 23 participants. Completed in 21 July 2020.
21 July 2020
Quick facts
| Lead sponsor | JeyaKumar Henry |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | other |
| Enrollment | 23 |
| Start date | 25 August 2017 |
| Primary completion | 21 July 2020 |
| Estimated completion | 21 July 2020 |
| Sites | 1 location across Singapore |
Drugs / interventions tested
- Soluble corn fiber — full drug profile →
- maltodextrin (MALTODEXTRIN) — full drug profile →
Conditions studied
- Pre Diabetes — all drugs for Pre Diabetes →
- Obesity — all drugs for Obesity →
Sponsor
JeyaKumar Henry
Who can join
Adults 21 to 60, male only, with Pre Diabetes or Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to describe the glycemic, insulinemic and appetitive responses to liquid and solid foods where either soluble fiber or maltodextrin are used as the carbohydrate substrate.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Role of Soluble Corn Fiber on Glycemic and Insulin Response.
Tan WSK, Chia PFW, Ponnalagu S, Karnik K, et al · · 2020 · cited 14× · PMID 32235569 · DOI 10.3390/nu12040961
Verify or expand the search:
- PubMed search for NCT03279107
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Soluble corn fiber
Trials testing the same drug.
- NCT06519877 — Fiber and Calcium Absorption in Older Men · Phase 2 · recruiting
Other recruiting trials for Pre Diabetes
Currently open trials in the same condition.
- NCT07252700 — Preventing Diabetes: Impact of an EMR-Based Intervention for Enhanced Pre-Diabetes Management in Primary Care · NA · recruiting
- NCT06986161 — Optimizing Mango's Glycemic Impact: Investigating Mango Consumption Timing in Prediabetic Individuals · NA · recruiting
- NCT06426277 — Effectiveness of the Brazilian Diabetes Prevention Program · NA · recruiting
- NCT06387797 — Primary and Secondary Prevention of Type 2 Diabetes Mellitus in Clark County · NA · recruiting
- NCT06555952 — MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors · NA · recruiting
Other JeyaKumar Henry trials
Trials by the same sponsor.
- NCT03964857 — Blended Oil Beneficial for Blood Lipids Management · NA · unknown
- NCT03257059 — Breakfast Consumption and Its Effects on Glycemic, Insulinemic and Non-Esterified Fatty Acids Responses · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03279107 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by JeyaKumar Henry
- Last refreshed: 20 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03279107.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing